Li and Porco, Jr.
FIGURE 2. Representative epoxyquinoid natural products synthesized in our laboratory.
Recently, the polyketides epoxyquinols A (6, Figure 2),
B (7),6 and epoxytwinol A (RKB-3564 D, 8)7 were isolated
by Osada and co-workers and shown to be potent anti-
angiogenesis agents.8 Angiogenesis, the formation of
capillary blood vessels from existing blood vessels,9 occurs
in cancer, chronic inflammation, and atherosclerosis.10
Combined with their novel highly oxygenated, heptacyclic
structures and their potential as probes to elucidate the
basic biological mechanisms of angiogenesis, the ep-
oxyquinols (6 and 7) have attracted immediate attention
in the synthetic community,11 including work in our
laboratory directed toward the syntheses of 6, 7,4f and
the related dimer epoxytwinol A (8).4g In continuation of
our studies toward the synthesis of epoxyquinoid natural
products4 and bioactive analogues,4c,5 herein we present
a full account of our syntheses of epoxyquinol dimers
6-8, including efforts to probe the chemical reactivities
of both epoxyquinol dimers and 2H-pyran precursors.
Synthetic Plan. We recently reported the biomimetic
synthesis12 of torreyanic acid (1), which was highlighted
by oxidation/oxaelectrocyclization13/endo Diels-Alder
dimerization of an epoxyquinone precursor (Figure 3).4a,b
Structural inspection indicates significant similarity
between the frameworks of the dimeric epoxyquinoid
natural products torreyanic acid (1) and epoxyquinol A
(6) (Figure 2).
In contrast to dimer 6, derived from endo [4 + 2]
dimerization of diastereomeric 2H-pyran monomers, ep-
oxyquinol dimer 7 arises from exo Diels-Alder dimer-
ization of two identical epoxyquinol 2H-pyran monomers
(Figure 4). At the outset of our studies, it was unclear
whether monomer 9 would undergo a comparable oxida-
tion/oxaelectrocyclization/Diels-Alder dimerization se-
quence. Epoxytwinol A (8) features a unique 3,8-
dioxatricyclo[4,2,2,22,5]dodeca-9,11-diene ring system,
which presumably arises via [4 + 4] cycloaddition of two
2H-pyran monomers, 10 or 10′. NMR analyses of 8 by
(6) Epoxyquinol A: (a) Kakeya, H.; Onose, R.; Koshino, H.; Yoshida,
A.; Kobayashi, K.; Kageyama, S.-I.; Osada, H. J. Am. Chem. Soc. 2002,
124, 3496. Epoxyquinol B: (b) Kakeya, H.; Onose, R.; Yoshida, A.;
Koshino, H.; Osada, H. J. Antibiot. 2002, 55, 829.
(7) (a) Osada, H.; Kakeya, H.; Konno, H.; Kanazawa, S. PCT Int.
Appl. 2002, WO 0288137. RKB-3564 D was recently named epoxy-
twinol A: (b) Kakeya, H.; Onose, Rie.; Koshino, H.; Osada, H. Chem.
Commun. 2005, 2575.
(8) Natural products with anti-angiogenesis activity: Fumagillin (a)
Ingber, D.; Fujita, T.; Kishmoto, S.; Sudo, K.; Kanamaru, T.; Brem,
H.; Folkman, J. Nature (London) 1990, 348, 555. Ovalicin (b) Corey,
E. J.; Guzman-Perez, A.; Noe, M. C. J. Am. Chem. Soc. 1994, 116,
12109. Borrelidin (c) Wakabayashi, T.; Kageyama, R.; Naruse, N.;
Tsukahara, N.; Funahashi, Y.; Kitoh, K.; Watanabe, Y. J. Antibiot.
1997, 50, 671. Azaspirene (d) Asami, Y.; Kakeya, H.; Onose, R.;
Yoshida, A.; Matsuzaki, H.; Osada, H. Org. Lett. 2002, 4, 2845.
Ageladine A (e) Fujita, M.; Nakao, Y.; Matsunaga, S.; Seiki, M.; Itoh,
Y.; Yamashita, J.; Soest, R. W. M.; Fusetani, N. J. Am. Chem. Soc.
2003, 125, 15700. For a review, see: (f) Paper, D. H. Planta Medica
1998, 64, 686.
(11) (a) Shoji, M.; Yamaguchi, J.; Kakeya, H.; Osada, H.; Hayashi,
Y. Angew. Chem., Int. Ed. 2002, 41, 3192. (b) Shoji, M.; Kishida, S.;
Takeda, M.; Kakeya, H.; Osada, H.; Hayashi, Y. Tetrahedron Lett.
2002, 43, 9155. (c) Mehta, G.; Islam, K. Tetrahedron Lett. 2003, 44,
3569. (d) Shoji, M.; Kishida, S.; Kodera, Y.; Shiina, I.; Kakeya, H.;
Osada, H.; Hayashi, Y. Tetrahedron Lett. 2003, 44, 7205. (e) Shoji, M.;
Imai, H.; Shima, I.; Kakeya, H.; Osada, H.; Hayashi, Y. J. Org. Chem.
2004, 69, 1548. (f) Mehta, G.; Islam, K. Tetrahedron Lett. 2004, 45,
3611. (g) Shoji, M.; Imai, H.; Mukaida, M.; Sakai, K.; Kakeya, H.;
Osada, H.; Hayashi, Y. J. Org. Chem. 2005, 70, 79. (h) Kuwahara, S.;
Imada, S. Tetrahedron Lett. 2005, 46, 547.
(9) Hertig, A. T. Contrib. Embryol. 1935, 25, 37.
(12) Recent review: de la Torre, M. C.; Sierra, M. A. Angew. Chem.,
Int. Ed. 2004, 43, 160.
(10) (a) Kim, K. J.; Li, B.; Winer, J.; Armanini, M.; Gillett, N.;
Phillips, H. S.; Ferrara, N. Nature 1993, 362, 841. (b) Folkman, J. Nat.
Med. 1995, 1, 27. (c) Deplanque, G.; Harris, A. L. Eur. J. Cancer 2000,
36, 1713. (d) Kerbel, R. S. Carcinogenesis 2000, 21, 505.
(13) For a review on valence isomerization of dienones and 2H-
pyrans, see: Krasnaya, Zh. A. Chem. Heterocycl. Compd. 1999, 35,
1255.
6054 J. Org. Chem., Vol. 70, No. 15, 2005